Asia-Pacific Americas Africa Europe Middle East

SOLARA ACTIVE PHARMA SCIENCE LIMITE

Company Profile:

Company Type: Factory (Manufacturer)

Company Introduction:

SOLARA ACTIVE PHARMA SCIENCE LIMITED is a leading Indian pharmaceutical company primarily engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs) and offering Contract Research and Manufacturing Services (CRAMS). Established in 2017, the company was formed from the demerger of the API business of Strides Shasun Ltd and the human API business of Sequent Scientific Ltd.

Headquartered in Bangalore, India, Solara operates multiple state-of-the-art manufacturing facilities that comply with stringent global regulatory standards, including those of the US FDA, EDQM, and others. The company focuses on developing and producing a diverse portfolio of high-quality, cost-effective APIs across various therapeutic segments.

Solara's business model emphasizes robust research and development capabilities, efficient large-scale manufacturing, and a strong global distribution network. They are committed to being a reliable partner in the pharmaceutical supply chain, serving customers worldwide with innovative and high-quality pharmaceutical solutions.

Enterprise Products

Solara Active Pharma Sciences Limited manufactures and sells a range of Active Pharmaceutical Ingredients (APIs) and intermediates. Key products include:

1. Ibuprofen

2. Metformin HCl

3. Gabapentin

4. Ursodeoxycholic Acid (UDCA)

5. Dexlansoprazole

6. Secnidazole

7. Itraconazole

8. Fluconazole

9. Ketoconazole

10. Ondansetron

11. Venlafaxine HCl

12. Sertraline HCl

13. Valsartan

14. Sacubitril

15. Varenicline Tartrate

16. Levothyroxine Sodium

17. Fexofenadine HCl

Business Registration Information:

Manager:

Mr. J. Chiranjeevi

Phone:

+91 44 4341 0300

E-mail:

investorrelations@solara.co.in

Official Website:
Address:

247, 4th Floor, Anna Salai, Teynampet, Chennai - 600 006, Tamil Nadu, India

This content is from AI, the data and information provided is for reference only and is not applicable to investment and purchase decisions. If there is any incorrect information, please contact customer service to correct it.